Prime Medicine, Inc. (PRME) Profit Margins
Over the twelve months to 2026-06-30, Prime Medicine, Inc. (PRME) had operating margin -4824.9%, net margin -4613.1%, free cash flow margin -3850.9%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PRMEPrime Medicine, Inc.Follow PRME — free
—
Price chart with a free account
- Market cap
- 665.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 30 Oct, in 6 days
| Line | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|
| Operating margin | -6787.4% | -4498.1% | -4824.9% | |
| Net margin | -6566.6% | -4342.4% | -4613.1% | |
| FCF margin | -4363.4% | -3607.4% | -3850.9% |
USD millions · SEC XBRL
Prime Medicine, Inc. — questions
- What is Prime Medicine, Inc.'s operating margin?
- -4824.9% over the twelve months to 2026-06-30.
- What is Prime Medicine, Inc.'s net profit margin?
- -4613.1% over the twelve months to 2026-06-30.
Every figure on this page comes from Prime Medicine, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.